Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.64 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.64 |
| ▸ | DGKA | P23743 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 4/20 | 0.57 |
| ▸ | MGLL | Q99685 | 1/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.51 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.51 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 1/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.51 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.51 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.51 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.51 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.51 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.51 |
| ▸ | CES2 | O00748 | 1/20 | 0.51 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12836601 | 1.00 | FFAR1 (0.64) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL12842107 | 0.96 | FFAR1 (0.63) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL11223716 | 0.96 | FFAR1 (0.63) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL27513328 | 0.94 | FFAR1 (0.66) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL142809 | 0.94 | FFAR1 (0.66) | FFAR1FFAR4DGKAFAAHMGLL | |
| Ethylene Glycol SCHEMBL5162980 | 0.94 | FFAR1 (0.66) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL25340998 | 0.94 | FFAR1 (0.69) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL20897199 | 0.94 | FFAR1 (0.69) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL20521729 | 0.94 | FFAR1 (0.69) | FFAR1FFAR4DGKAFAAHMGLL | |
| SCHEMBL22096921 | 0.94 | FFAR1 (0.69) | FFAR1FFAR4DGKAFAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | claimed |
| US-20100130718-A1 | Diols and Polyols | COGNIS IP MANAGEMENT GMBH (DE) | 2010-05-27 | — | — | US | claimed |
| WO-2008122364-A1 | DIOLS AND POLYOLS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-10-16 | — | — | WO | claimed |
| EP-1978013-A1 | Diols and polyols | Cognis IP Management GmbH (DE) | 2008-10-08 | — | — | EP | claimed |
| EP-2209547-B1 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | UNIV KANSAS (US) | 2018-06-20 | — | — | EP | disclosed |
| CN-101909729-B | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2014-10-22 | — | — | CN | disclosed |
| US-8801939-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2014-08-12 | — | — | US | disclosed |
| US-20130240781-A1 | Ozonolysis Reactions in Liquid CO2 and CO2-Expanded Solvents | ARCHER DANIELS MIDLAND COMPANY (US) | 2013-09-19 | — | — | US | disclosed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | disclosed |
| EP-2209547-A2 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | University Of Kansas (US) | 2010-07-28 | — | — | EP | disclosed |
| US-20100130718-A1 | Diols and Polyols | COGNIS IP MANAGEMENT GMBH (DE) | 2010-05-27 | — | — | US | disclosed |
| WO-2009061806-A2 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | UNIVERSITY OF KANSAS (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20090118498-A1 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | ARCHER DANIELS MIDLAND COMPANY | 2009-05-07 | — | — | US | disclosed |
| WO-2008122364-A1 | DIOLS AND POLYOLS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-10-16 | — | — | WO | disclosed |
| EP-1978013-A1 | Diols and polyols | Cognis IP Management GmbH (DE) | 2008-10-08 | — | — | EP | disclosed |
| US-4364743-A | ESTER AND MIDDLE OIL | ERNER WILLIAM E | 1982-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130718-A1 | Diols and Polyols | DECR2, HCAR2, HSD17B12 | FFAR1 261/4885FFAR4 534/4885DGKA 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.